{
  "meta": {
    "title": "Basic_Concepts_Of_Neoplasia",
    "url": "https://brainandscalpel.vercel.app/basic-concepts-of-neoplasia-2475ddea.html",
    "scrapedAt": "2025-11-29T18:32:22.458Z"
  },
  "questions": [
    {
      "id": 14292,
      "choices": [
        {
          "id": 57129,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic cancer </span></span></span></p>"
        },
        {
          "id": 57130,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thymoma </span></span></p>"
        },
        {
          "id": 57131,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Hodgkin lymphoma </span></span></span></p>"
        },
        {
          "id": 57132,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Squamous cell carcinoma </span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An elderly female with mediastinal mass undergoes a microscopic examination showing red cell aplasia. What is the likely diagnosis? </span></span></span></p>",
      "unique_key": "Q5311941",
      "question_audio": null,
      "question_video": null,
      "map_id": 31978,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. &nbsp;Thymoma </span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The description of an <strong>elderly female with a mediastinal mass </strong>and microscopic examination showing<strong> red cell aplasia </strong>is suggestive of a<strong> thymoma</strong>. <strong>Thymomas </strong>are tumors arising from the <strong>thymic epithelial cells</strong> in the thymus, which is located in the <strong>mediastinum.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymomas</strong> can be associated with various<strong> paraneoplastic syndromes</strong>, and one of them is <strong>pure red cell aplasia.</strong>&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Direct lines from Robbins. &ldquo;In addition to <strong>myasthenia gravis</strong>, <strong>thymomas </strong>may be associated with <strong>several other paraneoplastic syndromes.</strong> These include in rough order of frequency, <strong>pure red cell aplasia, hypogammaglobulinemia, and multi organ autoimmunity</strong>&rdquo;. </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymoma </strong>is a <strong>tumor of the thymic epithelial cells </strong>and can present as a <strong>mediastinal mass</strong>. It is associated with <strong>several paraneoplastic syndromes </strong>including <strong>pure red cell aplasia</strong>, which leads to <strong>severe anemia due to the failure of the bone marrow to produce red blood cells</strong>, <strong>myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bronchogenic cancer</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> often presents as a <strong>mediastinal mass</strong>, especially in <strong>smokers</strong>. However, it is not commonly associated with red cell aplasia, but rather with other<strong> paraneoplastic syndromes such as hypercalcemia (due to production of PTH-related protein) or the secretion of ADH or ACTH.</strong></span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Non-Hodgkin lymphoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can present as a<strong> mediastinal mass</strong>. It may cause <strong>bone marrow </strong>involvement leading to various <strong>cytopenias </strong>but is<strong> not </strong>specifically associated with<strong> pure red cell aplasia</strong>.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Squamous cell carcinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> typically arises from the<strong> epithelial cells of the skin or mucous membranes </strong>and is not commonly found within the mediastinum. It is associated with <strong>paraneoplastic syndromes</strong>, but not typically with red cell aplasia.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thymoma </strong>is the likely diagnosis in an elderly patient with a <strong>mediastinal mass and red cell aplasia, as thymomas </strong>are associated with this condition and other<strong> paraneoplastic syndromes </strong>such as <strong>myasthenia gravis, hypogammaglobulinemia, and multi-organ autoimmunity. </strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><em><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p493 </span></span></em></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><em><span style=\"font-size:12.0pt\"> </span></em></strong></span></span></p>",
      "correct_choice_id": 57130,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13657,
      "choices": [
        {
          "id": 54589,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It involves both alleles of RB at chromosome locus 13q14 </span></span></span></span></p>"
        },
        {
          "id": 54590,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In sporadic cases, both normal RB alleles must undergo somatic mutation in the same retinoblast </span></span></span></span></p>"
        },
        {
          "id": 54591,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial type is inherited as an autosomal recessive trait</span></span></span></span></p>"
        },
        {
          "id": 54592,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In familial cases, children inherit one defective copy of the RB gene and the other copy is normal</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is false about Knudson&#39;s two-hit hypothesis theory on retinoblastoma?</span></span></p>",
      "unique_key": "Q5881570",
      "question_audio": null,
      "question_video": null,
      "map_id": 31982,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Familial type is inherited as an autosomal recessive trait </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retinoblastoma<strong> </strong>is inherited as an autosomal dominant trait.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Knudson&#39;s hypothesis</strong>, also known as the <strong>two-hit hypothesis or multiple-hit hypothesis states </strong>that cancer is the result of accumulated<strong> mutations in a cell&#39;s DNA</strong>.</span></span></span></span><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Two mutations </strong>(hits), involving<strong> both alleles of RB at chromosome locus 13q14, </strong>are required to produce<strong> retinoblastoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>In sporadic cases</strong>, both normal<strong> RB alleles </strong>must undergo <strong>somatic mutation </strong>in the same retinoblast (two hits).</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;In familial cases, children inherit one<strong> defective copy of the RB gene in the germline (the first hit), </strong>and the other copy is normal.<strong> Retinoblastoma </strong>develops when the<strong> normal RB allele </strong>is <strong>mutated in retinoblasts </strong>as a result of a <strong>spontaneous somatic mutation (the second hit).</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Familial retinoblastoma </strong>is inherited in <strong>an autosomal dominant pattern, </strong>not autosomal recessive. According to<strong> Knudson&#39;s two-hit hypothesis</strong>, a<strong> single inherited mutation </strong>in<strong> one allele of the RB gene </strong>is sufficient to predispose to<strong> retinoblastoma</strong>, but <strong>a second somatic mutation </strong>in the<strong> other allele </strong>must occur for the <strong>cancer to develop</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54591,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13627,
      "choices": [
        {
          "id": 54469,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-3, C-4, D-1</span></span></span></span></p>"
        },
        {
          "id": 54470,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-3, B-2, C-1, D-4</span></span></span></span></p>"
        },
        {
          "id": 54471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-4, B-3, C-2, D-1</span></span></span></span></p>"
        },
        {
          "id": 54472,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A-2, B-1, C-4, D-3</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following genes correctly with their tumors:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/08/screenshot-2024-02-08-150523.jpg\" style=\"height:344px; width:700px\" /></span></span></p>",
      "unique_key": "Q5580125",
      "question_audio": null,
      "question_video": null,
      "map_id": 31968,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) A-2, B-1, C-4, D-3</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-100314.JPG\" style=\"height:374px; width:757px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C- myc </strong>is associated with <strong>Burkitt&rsquo;s lymphoma </strong>(Ref: Robbins&hellip;316) </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PLAG 1 </strong>is associated with<strong> pleomorphic adenoma </strong>(Ref: Robbins&hellip;748)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>N myc </strong>is associated with <strong>neuroblastoma </strong>(Ref: Robbins&hellip;289)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Rb </strong>is associated with <strong>retinoblastoma </strong>(Ref: Robbins&hellip;147)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 147, 289, 316, 748</span></span></strong></span></span></p>",
      "correct_choice_id": 54472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16235,
      "choices": [
        {
          "id": 64900,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Papillary carcinoma of thyroid</span></p>"
        },
        {
          "id": 64901,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adenocarcinoma of colon</span></p>"
        },
        {
          "id": 64902,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Meningioma</span></p>"
        },
        {
          "id": 64903,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary cancer of the ovary</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psammoma bodies are seen in all except:</span></p>",
      "unique_key": "Q6839929",
      "question_audio": null,
      "question_video": null,
      "map_id": 31991,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Adenocarcinoma of colon</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Psammoma bodies </strong>are <strong>not a common feature of colon adenocarcinomas</strong>. They are more typically <strong>associated with certain other epithelial tumors</strong>, like <strong>ovarian and thyroid papillary carcinomas</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Papillary carcinoma of thyroid:</strong> It is known to <strong>frequently have psammoma bodies</strong>, which are <strong>calcified concentric structures </strong>found within the tumor tissue.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Meningioma:</strong> This <strong>benign brain tumor </strong>often contains <strong>psammoma bodies</strong>, contributing to its <strong>classic histological appearance</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Papillary cancer of the ovary (serous cystadenoma of the ovary):</strong> Similar to <strong>papillary thyroid carcinoma</strong>, <strong>ovarian papillary tumors </strong>can also <strong>exhibit psammoma bodies</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Psammoma bodies </strong>are <strong>calcified structures </strong>often <strong>found in certain neoplasms </strong>such as <strong>papillary carcinoma </strong>of the <strong>thyroid, meningioma</strong>, <strong>papillary cancer of the ovary </strong>(serous cystadenoma of the ovary) and occasionally in mesothelioma<strong>&nbsp;</strong>but are not typically seen in <strong>adenocarcinoma of the colon</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1098</strong></span></p>",
      "correct_choice_id": 64901,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13658,
      "choices": [
        {
          "id": 54593,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-a, 3-d, 4-b</span></span></span></span></p>"
        },
        {
          "id": 54594,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-d, 3-b, 4-a</span></span></span></span></p>"
        },
        {
          "id": 54595,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-a, 4-d</span></span></span></span></p>"
        },
        {
          "id": 54596,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the Immuno- markers with its associated neoplasm:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154335.jpg\" style=\"height:237px; width:700px\" /></span></span></span></p>",
      "unique_key": "Q9582942",
      "question_audio": null,
      "question_video": null,
      "map_id": 31983,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1-b, 2-c, 3-d, 4-a</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/25/screenshot-2024-04-25-123409.png\" style=\"height:229px; width:800px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 270</span></span></strong></span></span></p>",
      "correct_choice_id": 54596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13660,
      "choices": [
        {
          "id": 54601,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholic cirrhosis</span></span></span></span></p>"
        },
        {
          "id": 54602,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma colon</span></span></span></span></p>"
        },
        {
          "id": 54603,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma prostate</span></span></span></span></p>"
        },
        {
          "id": 54604,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emphysema</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A physician is considering the differential diagnoses for a patient&#39;s elevated serum tumor marker levels. Carcinoembryonic antigen (CEA) is known to be elevated in various malignancies and benign conditions. Which of the following conditions is NOT typically associated with an elevated CEA level?</span></span></p>",
      "unique_key": "Q2492802",
      "question_audio": null,
      "question_video": null,
      "map_id": 31984,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Carcinoma prostate</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prostate specific antigen (PSA) is elevated in carcinoma prostate </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma of the prostate</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>CEA </strong>is<strong> not a marker </strong>for <strong>prostate cancer</strong>. Instead, <strong>prostate-specific antigen (PSA) </strong>is the commonly used <strong>tumor marker </strong>for <strong>diagnosing and monitoring prostate cancer.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alcoholic cirrhosis&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcoholic cirrhosis can lead to<strong> elevated CEA levels. </strong>CEA is <strong>not specific </strong>for <strong>malignancy </strong>and can be raised in a variety of<strong> benign liver conditions, including cirrhosis, </strong>especially when related to <strong>alcohol use</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carcinoma of the colon&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CEA </strong>levels are frequently <strong>elevated </strong>in <strong>colorectal cancer </strong>and can be used as a marker for monitoring <strong>treatment response or disease </strong>recurrence after the removal of the<strong> primary tumor</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Emphysema&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic lung conditions, including emphysema, can also result in<strong> elevated CEA levels</strong>, even though these are <strong>not malignant conditions. Smoking, </strong>which is a <strong>risk factor </strong>for<strong> emphysema</strong>, can itself cause <strong>elevated CEA levels.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carcinoma of the prostate</strong>, is<strong> not </strong>associated with <strong>elevated CEA levels</strong>. Instead,<strong> prostate-specific antigen (PSA) </strong>is the<strong> tumor marker </strong>commonly elevated in <strong>prostate cancer</strong>.<strong> CEA </strong>is used primarily for<strong> monitoring colorectal cancer </strong>and can be <strong>elevated </strong>in various <strong>benign conditions</strong>, including<strong> liver and lung diseases</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-154619.jpg\" style=\"height:348px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 336</span></span></strong></span></span></p>",
      "correct_choice_id": 54603,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13637,
      "choices": [
        {
          "id": 54509,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation of the PTEN gene</span></span></span></p>"
        },
        {
          "id": 54510,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation of the CDKN2 gene</span></span></span></p>"
        },
        {
          "id": 54511,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation of RB gene</span></span></span></p>"
        },
        {
          "id": 54512,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mutation of the WT gene</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 31-year-old female has fecal blood identified during a physical examination. A colonoscopy reveals an ulcerated mass in her proximal rectum. In the past, she was operated and treated for a ductal carcinoma of her left breast and a malignant thyroid tumor. Of the following, what is the most likely mutation if she is diagnosed with Cowden&rsquo;s syndrome?</span></span></p>",
      "unique_key": "Q4664125",
      "question_audio": null,
      "question_video": null,
      "map_id": 31970,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Mutation of the PTEN gene </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Patients </strong>with <strong>Cowden&rsquo;s syndrome </strong>develop <strong>colorectal, thyroid, and breast neoplasms. </strong>The underlying mutation is that of <strong>PTEN (located on chromosome 10q23)</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Mutations of <strong>CDKN2 </strong>are associated with <strong>malignant melanoma</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>RB </strong>with <strong>retinoblastoma. </strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;WT </strong>with <strong>Wilms tumor</strong>&nbsp; </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Patients </strong>with<strong> Cowdens syndrome </strong>have&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>mutation of the PTEN gene</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page:292 table: 7.7</span></span></strong></span></span></p>",
      "correct_choice_id": 54509,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13642,
      "choices": [
        {
          "id": 54529,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulation of apoptosis</span></span></span></span></p>"
        },
        {
          "id": 54530,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of angiogenesis</span></span></span></span></p>"
        },
        {
          "id": 54531,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of cell cycle arrest </span></span></span></span></p>"
        },
        {
          "id": 54532,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Promotion of cell proliferation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old man presents to the emergency department with persistent abdominal pain and diarrhea. CT scan reveals the presence of a tumor in the pancreas. Biopsy confirms the diagnosis of pancreatic adenocarcinoma. Genetic testing reveals a mutation in the KRAS proto-oncogene. Which of the following best describes the role of KRAS in this case?</span></span></span></span></p>",
      "unique_key": "Q1479544",
      "question_audio": null,
      "question_video": null,
      "map_id": 31972,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Promotion of cell proliferation</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KRAS&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>proto-oncogene</strong> that encodes for a protein involved in <strong>cell signaling pathways </strong>that regulate<strong> cell growth and division</strong>. <strong>Mutations in KRAS </strong>can lead to the<strong> activation of these pathways, promoting cell proliferation and survival</strong>. <strong>KRAS mutations </strong>are common in<strong> pancreatic adenocarcinoma </strong>and are associated with a <strong>poorer prognosis</strong></span></span></span></span></p>",
      "correct_choice_id": 54532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13622,
      "choices": [
        {
          "id": 54449,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperuricemia </span></span></span></p>"
        },
        {
          "id": 54450,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia</span></span></span></p>"
        },
        {
          "id": 54451,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperphosphatemia</span></span></span></p>"
        },
        {
          "id": 54452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with Burkitt lymphoma presents with lethargy, weakness, and oliguria after receiving the first cycle of chemotherapy. Laboratory tests reveal abnormalities consistent with tumor lysis syndrome (TLS). Which of the following laboratory findings is LEAST likely to be associated with this condition?</span></span></p>",
      "unique_key": "Q9062896",
      "question_audio": null,
      "question_video": null,
      "map_id": 31964,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Hypercalcemia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor lysis syndrome </strong>is associated with<strong> Burkitt lymphoma, acute lymphoblastic leukemia (ALL), chronic tumors (CLL) and uncommonly solid tumors.</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is associated with<strong> hypocalcemia </strong>and NOT hypercalcemia. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is NOT a feature of TLS; rather, <strong>hypocalcemia is commonly seen </strong>due to the precipitation of<strong> calcium </strong>with the <strong>elevated phosphate released from lysed cells.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanations</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperuricemia&nbsp;</strong>is typically seen in <strong>TLS </strong>due to the <strong>increased </strong>turnover of <strong>nucleic acids from rapid cell lysis</strong>, leading to excess production of <strong>uric acid</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperkalemia</strong> results from the <strong>release of potassium</strong>, the most abundant<strong> intracellular cation</strong>, into the<strong> bloodstream </strong>when <strong>cells lyse</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperphosphatemia</strong> occurs due to the release of<strong> intracellular phosphate into the extracellular fluid </strong>during cell lysis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tumor lysis </strong>syndrome is characterized by<strong> hyperuricemia, hyperkalemia, and hyperphosphatemia, </strong>but<strong> not hypercalcemia</strong>; instead, <strong>hypocalcemia </strong>occurs due to the <strong>complexing of calcium with elevated phosphate levels</strong>. </span></span></span></p>",
      "correct_choice_id": 54452,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13647,
      "choices": [
        {
          "id": 54549,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a proto-oncogene</span></span></span></span></p>"
        },
        {
          "id": 54550,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is involved in DNA repair</span></span></span></span></p>"
        },
        {
          "id": 54551,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a tumor suppressor gene</span></span></span></span></p>"
        },
        {
          "id": 54552,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is not involved in colon cancer</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient presents with a family history of colon cancer. They undergo genetic testing, which reveals a mutation in the APC gene. Which of the following is true about APC? </span></span></p>",
      "unique_key": "Q9021906",
      "question_audio": null,
      "question_video": null,
      "map_id": 31975,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It is a tumor suppressor gene</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a tumor suppressor gene.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> APC gene </strong>encodes a <strong>protein </strong>that helps regulate<strong> cell division </strong>and may <strong>prevent cells from growing and dividing too rapidly </strong>or in an <strong>uncontrolled way</strong>. <strong>Mutations in the APC gene </strong>can lead to<strong> unchecked cellular proliferation</strong>, predisposing individuals to <strong>cancer, </strong>particularly<strong> colorectal cancer.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; It is a proto-oncogene.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proto-oncogenes are<strong> normal genes </strong>that can become <strong>oncogenes due to mutations or increased expression</strong>.<strong> Oncogenes </strong>can cause the <strong>cells to grow and proliferate excessively</strong>. The <strong>APC gene</strong>, however, functions as a <strong>tumor suppressor gene, not a proto-oncogene.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is involved in DNA repair.&nbsp;&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>DNA repair </strong>mechanisms are essential in the <strong>prevention of cancer</strong>, the <strong>APC gene itself is not </strong>primarily involved in<strong> DNA repair processes</strong>. Its <strong>primary function </strong>relates to the<strong> regulation of cell growth and division.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It is not involved in colon cancer.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This statement is<strong> incorrect</strong>. The<strong> APC gene </strong>is implicated in<strong> colon cancer</strong>, as<strong> mutations </strong>in this<strong> gene </strong>are commonly found in <strong>both sporadic and hereditary forms of colorectal cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>APC gene </strong>is a<strong> tumor suppressor gene. </strong>Mutations in the<strong> APC gene </strong>lead to a<strong> loss of function</strong>, resulting in<strong> increased cell proliferation and a higher risk for developing colorectal cancer</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13675,
      "choices": [
        {
          "id": 54661,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54662,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54663,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bladder carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient notices spontaneously appearing and disappearing painful, linearly arranged nodules in different parts of the body. Which of the following malignancies is not associated with this clinical presentation?</span></span></span></span></p>",
      "unique_key": "Q7039975",
      "question_audio": null,
      "question_video": null,
      "map_id": 31989,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Bladder carcinoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical presentation is suggestive of <strong>migratory thrombophlebitis (Trousseau syndrome) </strong>and it is <strong>not associated </strong>with <strong>bladder carcinoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> bladder carcinoma </strong>can be associated with a<strong> hypercoagulable state</strong>, it is<strong> less commonly </strong>linked to<strong> Trousseau syndrome </strong>compared to the <strong>adenocarcinomas of the pancreas, lung, and gastrointestinal or gynecologic malignancies.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Uterine carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine carcinoma, particularly when<strong> adenocarcinoma</strong>, can be associated with <strong>Trousseau syndrome</strong> due to its <strong>propensity to induce a hypercoagulable state</strong>, leading to<strong> venous thromboembolism.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pancreatic carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pancreatic carcinoma </strong>is strongly associated with <strong>Trousseau syndrome</strong>. The tumor&#39;s release of<strong> mucins and procoagulant substances </strong>can trigger a <strong>hypercoagulable state</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Bronchogenic carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma, especially <strong>adenocarcinoma subtype,</strong> is known to produce substances that<strong> activate the coagulation system, </strong>thus it can be associated with<strong> Trousseau syndrome.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bladder carcinoma </strong>is<strong> not </strong>commonly associated with <strong>Trousseau syndrome</strong>, which is characterized by <strong>migratory thrombophlebitis </strong>and is often seen with <strong>deep-seated adenocarcinomas </strong>like those of the <strong>pancreas, lung, and other visceral organs.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 329</span></span></strong></span></span></p>",
      "correct_choice_id": 54664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13643,
      "choices": [
        {
          "id": 54533,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy</span></span></span></span></p>"
        },
        {
          "id": 54534,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplasia</span></span></span></span></p>"
        },
        {
          "id": 54535,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaplasia</span></span></span></span></p>"
        },
        {
          "id": 54536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to her primary care physician for a routine health check-up. She has no complaints and her medical history is unremarkable. She undergoes a Pap smear as part of her cervical cancer screening. The cytology report describes disorganized growth of cells with hyperchromatic nuclei. Which of the following best characterizes the cellular changes seen in this patient&#39;s Pap smear?</span></span></p>",
      "unique_key": "Q6352577",
      "question_audio": null,
      "question_video": null,
      "map_id": 31973,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Dysplasia </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pap smear </strong>having <strong>disorganised growth of the cells </strong>with <strong>hyperchromatic nuclei </strong>is suggestive of<strong> dysplasia</strong>.<strong> Carcinoma </strong>is diagnosed when <strong>abnormal mitotic figures </strong>are <strong>discovered </strong>and is called <strong>invasive </strong>when<strong> basement membrane is affected.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dysplasia&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is characterized by<strong> abnormal growth and disorganization of cells</strong>, often with variations in <strong>size, shape, and orientation</strong>. The term is often used when referring to<strong> precancerous or potentially premalignant conditions</strong>. In a <strong>Pap smear, dysplastic cells with hyperchromatic (darkly staining) nuclei </strong>suggest a higher likelihood of<strong> progressing to cervical cancer, </strong>especially if<strong> abnormal mitotic figures </strong>are present.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypertrophy:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypertrophy refers to an<strong> increase in the size of cells</strong>, leading to an <strong>increase in the size of the organ</strong>. It is usually seen in response to <strong>increased demand or stimulation by hormones or growth factors</strong>.<strong> Unlike hyperplasia</strong>, hypertrophy <strong>does not involve </strong>an<strong> increase in the number of cells</strong>. An example would be the<strong> increase in muscle mass due to exercise.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metaplasia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaplasia is the <strong>reversible change from one type of cell to another due to abnormal stimulus</strong>, which can potentially <strong>predispose to malignancy </strong>if the stimulus<strong> persists</strong>. A classic example is <strong>Barrett&rsquo;s esophagus</strong>, where the <strong>normal squamous epithelium of the esophagus changes to a columnar epithelium </strong>in response to <strong>chronic gastric acid exposure</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hyperplasia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperplasia is <strong>an increase in the number of cells in an organ or tissue, </strong>which may subsequently<strong> increase the size of the organ or tissue. </strong>It is a response to a <strong>stimulus </strong>and is usually a <strong>controlled process</strong>. <strong>Hyperplasia </strong>can be a <strong>physiological response</strong>, such as the <strong>proliferation of glandular epithelium </strong>of the<strong> female breast at puberty or pathologic </strong>as seen in <strong>endometrial hyperplasia.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dysplasia, </strong>is a term used to describe <strong>disorganized growth of cells with varying size, shape, and orientation, </strong>often with <strong>hyperchromatic nuclei, </strong>suggestive of a <strong>precancerous state</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th/e p719-720</span></span></strong></span></span></p>",
      "correct_choice_id": 54534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13638,
      "choices": [
        {
          "id": 54513,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BRCA1 is an oncogene </span></span></span></span></p>"
        },
        {
          "id": 54514,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">EGFR positive in non small cell cancer&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 54515,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Her 2 amplification is seen in most breast cancer&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 54516,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">N myc&nbsp; is a tumor suppressor gene&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of tumor biology, which of the following statements is correct?</span></span></p>",
      "unique_key": "Q4458746",
      "question_audio": null,
      "question_video": null,
      "map_id": 31971,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) EGFR positive in non small cell cancer</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>EGFR positivity </strong>is commonly seen in <strong>non-small cell lung cancer</strong>, particularly<strong> adenocarcinoma subtype, </strong>and can be a target for specific therapies.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&nbsp;BRCA1 </strong>is<strong> not an oncogene</strong> but a<strong> tumor suppressor gene. Mutations in BRCA1 </strong>are associated with an <strong>increased risk of</strong> <strong>breast and ovarian cancers.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Her2 </strong>amplification occurs in<strong> some breast cancer </strong>cases but is <strong>not seen </strong>in the <strong>majority. </strong>It is significant because<strong> Her2 status can affect treatment options and prognosis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>N myc </strong>is a<strong> proto-oncogene</strong>, <strong>not a tumor suppressor gene</strong>. It can become an <strong>oncogene </strong>when<strong> mutated or overexpressed, </strong>as seen in some cases of <strong>neuroblastoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>BRCA1 </strong>is a tumor<strong> suppressor gene</strong>,<strong> EGFR </strong>can be overexpressed in <strong>non-small cell lung cancer,</strong> <strong>Her2 </strong>is amplified in a <strong>subset of breast cancers</strong>, and<strong> N myc </strong>is a<strong> proto-oncogene </strong>associated with certain types of cancer <strong>(neuroblastoma). </strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/285, 292</span></span></strong></span></span></p>",
      "correct_choice_id": 54514,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13646,
      "choices": [
        {
          "id": 54545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aberrant expression of a receptor tyrosine kinase</span></span></span></span></p>"
        },
        {
          "id": 54546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An inborn defect in DNA repair</span></span></span></span></p>"
        },
        {
          "id": 54547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemical carcinogenesis</span></span></span></span></p>"
        },
        {
          "id": 54548,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DNA viral infection</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 8-year-old child is referred to a dermatologist for several &quot;suspicious&quot; pigmented lesions on his face and neck. Further history reveals the patient has had problems seeing out of his right eye; he is referred to an ophthalmologist, who diagnoses ocular melanoma. Based on the patient&rsquo;s symptoms, the diagnosis of xeroderma pigmentosum is considered. This condition results from?</span></span></p>",
      "unique_key": "Q5058629",
      "question_audio": null,
      "question_video": null,
      "map_id": 31974,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) An inborn defect in DNA repair</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xeroderma pigmentosum </strong>is a <strong>hereditary DNA defect </strong>with a <strong>deficiency </strong>in the <strong>ability to repair ultraviolet (sunlight)-induced thymine dimers</strong>. <strong>Faulty repair </strong>leads to <strong>increased sun sensitivity</strong>, with a <strong>predilection to develop skin lesions </strong>and<strong> skin cancers on exposed skin, </strong>as well as<strong> ocular melanomas. </strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Aberrant expression </strong>of the<strong> gene </strong>for a<strong> receptor tyrosine kinase</strong>, such as the<strong> Her-2/neu gene product</strong>, can cause<strong> breast cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chemical carcinogens </strong>have <strong>highly reactive electrophile groups </strong>that directly<strong> damage DNA</strong>, leading to<strong> mutations and eventually cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>retrovirus </strong>is responsible for the<strong> development of T-cell leukemia/lymphoma</strong>. </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xeroderma pigmentosum </strong>is a condition resulting from a<strong> hereditary deficiency </strong>in the<strong> nucleotide excision repair pathway</strong>, leading to an <strong>inability to repair UV-induced thymine dimers</strong>, with resultant<strong> increased skin and ocular malignancies</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54546,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13676,
      "choices": [
        {
          "id": 54665,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 54666,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 54667,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
        },
        {
          "id": 54668,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are oncofetal antigens?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Alpha-fetoprotein</span></li><li><span style=\"font-size:12.0pt;\">Carcinoembryonic antigen</span></li><li><span style=\"font-size:12.0pt;\">Human chorionic gonadotropin</span></li><li><span style=\"font-size:12.0pt;\">Placental alkaline phosphatase</span></li><li><span style=\"font-size:12.0pt;\">Immunoglobulins</span></li></ol>",
      "unique_key": "Q6411814",
      "question_audio": null,
      "question_video": null,
      "map_id": 31990,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein (AFP) and carcinoembryonic antigen (CEA) are oncofetal antigens.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein</strong> is a valuable clinical aid in <strong>diagnosis, prognosis, and monitoring of the following tumors:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Primary hepatocellular carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Hepatoblastoma</span></li><li><span style=\"font-size:12.0pt;\">Non-seminomatous testicular germ cell tumors</span></li><li><span style=\"font-size:12.0pt;\">Embryonal carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Teratomas</span></li><li><span style=\"font-size:12.0pt;\">Choriocarcinoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Carcinoembryonic antigen </strong>is normally detected in the<strong> glycocalyx of fetal epithelial cells</strong>. It is useful in <strong>detection, assessing recurrence, and prognosis </strong>of the following tumors:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Adenocarcinoma of lung</span></li><li><span style=\"font-size:12.0pt;\">Colorectal carcinoma</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CEA levels &gt;5 g/dL </strong>are noted in<strong> ascitic fluid </strong>associated with <strong>malignancy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Human chorionic gonadotropin:</strong> Not an oncofetal antigen; it is a placental hormone, elevated in choriocarcinoma, testicular tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Placental alkaline phosphatase: </strong>A placental enzyme, considered a tumor-associated antigen, but not truly oncofetal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Immunoglobulins:</strong> These are normal adult proteins; elevated in plasma cell dyscrasias (e.g., multiple myeloma), but not oncofetal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Alpha-fetoprotein and carcinoembryonic antigen </strong>are<strong> oncofetal antigens</strong>, which are expressed during<strong> fetal development and re-expressed </strong>in certain <strong>malignancies, </strong>aiding in the<strong> diagnosis, prognosis, and monitoring of these cancers.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins and Cotran pathologic basis of disease 10th edition page: 336</strong></span></p>",
      "correct_choice_id": 54668,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13672,
      "choices": [
        {
          "id": 54649,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchogenic carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54650,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma of the pancreas </span></span></span></span></p>"
        },
        {
          "id": 54651,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esophageal carcinoma </span></span></span></span></p>"
        },
        {
          "id": 54652,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute myeloid leukemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old patient presents with loss of weight and appetite. On clinical examination, grade IV clubbing is evident. Imaging shows periosteal new bone formation and left knee joint effusion. Which of the following tumors is associated with this condition?</span></span></p>",
      "unique_key": "Q9769880",
      "question_audio": null,
      "question_video": null,
      "map_id": 31987,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Bronchogenic carcinoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical history is suggestive of<strong> hypertrophic osteoarthropathy</strong>. It is commonly associated with<strong> bronchogenic carcinoma. </strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bronchogenic carcinoma</strong>, particularly <strong>non-small cell lung cancer</strong>, is the most common cause of<strong> hypertrophic osteoarthropathy</strong>, which is characterized by<strong> periosteal new bone formation, arthritis of adjacent joints, and clubbing.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carcinoma of the pancreas:&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While patients with pancreatic cancer may develop<strong> paraneoplastic syndromes, hypertrophic osteoarthropathy </strong>is<strong> not </strong>typically associated with this <strong>type of malignancy.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Esophageal carcinoma:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Esophageal carcinoma </strong>can be associated with <strong>paraneoplastic phenomena </strong>including<strong> clubbing</strong>, but it is<strong> less </strong>commonly associated with <strong>hypertrophic osteoarthropathy </strong>compared to bronchogenic carcinoma.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acute myeloid leukemia:&nbsp;</span></span></strong></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hematologic </strong>malignancies like<strong> AML </strong>are <strong>not </strong>commonly associated with<strong> hypertrophic osteoarthropathy</strong>. <strong>Paraneoplastic syndromes </strong>are more commonly associated with <strong>solid tumors.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hypertrophic osteoarthropathy </strong>is characterized by the following:</span></span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Periosteal new bone formation</strong>, primarily at the <strong>distal ends of long bones, metatarsals, metacarpals, and proximal phalanges</strong></span></span></span></span></li>\r\n\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arthritis of the adjacent joints</span></span></span></span></strong></li>\r\n\t<li><strong><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clubbing of the digits</span></span></span></span></strong></li>\r\n</ul>",
      "correct_choice_id": 54649,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13623,
      "choices": [
        {
          "id": 54453,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Number of positive lymph nodes</span></span></span></span></p>"
        },
        {
          "id": 54454,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Size of the tumor</span></span></span></span></p>"
        },
        {
          "id": 54455,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metastatic spread to another organ</span></span></span></span></p>"
        },
        {
          "id": 54456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Number of mitotic figures per high power-field</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In reviewing the pathology report for a patient diagnosed with colonic adenocarcinoma, which of the following findings is most indicative of the tumor&#39;s grade?</span></span></p>",
      "unique_key": "Q8748472",
      "question_audio": null,
      "question_video": null,
      "map_id": 31965,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Number of mitotic figures per high power field.</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> grade of a tumor </strong>is its <strong>degree of histologic differentiation </strong>(e.g., <strong>well, moderate, or poorly differentiated</strong>) and represents a <strong>subjective determination by the pathologist </strong>as to how closely the <strong>tumor resembles the tissue type from which it arose </strong>(e.g., in <strong>colonic adenocarcinoma</strong>, whether the<strong> tumor cells appear like normal glandular epithelium</strong>). In determining the <strong>grade of the tumor</strong>, the<strong> histologic appearance of the tumor </strong>is <strong>important, </strong>including the <strong>number of mitotic figures per high-power field</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>number of mitotic figures </strong>per high-power field is an important factor in <strong>grading a tumor</strong>. It provides information about the <strong>proliferative activity of the tumor cells</strong> and how<strong> undifferentiated the tumor tissue </strong>is compared to the <strong>normal tissue</strong> from which it <strong>originated.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>the number of positive lymph nodes </strong>is crucial for <strong>staging a tumor </strong>under the<strong> &#39;N&#39; category in the TNM classification system</strong>, it <strong>does not </strong>determine the <strong>histologic grade of the tumor</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> size of the tumor </strong>is used to determine the<strong> &#39;T&#39; category in the TNM system </strong>and contributes to the <strong>staging, </strong>but <strong>not grading, of cancer</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> presence of metastasis </strong>is classified under the <strong>&#39;M&#39; category of the TNM system </strong>and, like<strong> A and B, is used in staging </strong>rather than grading.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> grade of a tumor </strong>is determined by its <strong>histologic differentiation, </strong>which includes the<strong> assessment of mitotic activity</strong>, specifically the<strong> number of mitotic figures </strong>per <strong>high power field</strong>, and<strong> not </strong>by the <strong>TNM staging factors </strong>such as <strong>tumor size, nodal involvement, or metastasis</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 246</span></span></strong></span></span></p>",
      "correct_choice_id": 54456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13624,
      "choices": [
        {
          "id": 54457,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of apoptosis</span></span></span></span></p>"
        },
        {
          "id": 54458,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abnormal GTPase activity</span></span></span></span></p>"
        },
        {
          "id": 54459,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abnormal tyrosine kinase activity</span></span></span></span></p>"
        },
        {
          "id": 54460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Up-regulation of cytokine receptor</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old male presents to his family physician because of complaints of blood in his stool and intermittent constipation. Fecal occult blood testing is positive. A colonoscopy is performed, revealing a large adenocarcinoma of the sigmoid colon. As the tumor was removed, a researcher tested the tumor and identified a mutation of RAS gene. Of the following, what was one mechanism by which the tumor developed?</span></span></p>",
      "unique_key": "Q6432946",
      "question_audio": null,
      "question_video": null,
      "map_id": 31966,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Abnormal GTPase activity</span></span></strong></span></span><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mutations </strong>in <strong>RAS </strong>commonly lead to<strong> abnormal GTPase activity</strong>. <strong>Normally, RAS has intrinsic GTPase activity</strong>, allowing it to <strong>cycle between an active and inactive state</strong>. A<strong> mutation </strong>can cause <strong>RAS to remain in an active state</strong>, continuously signaling for<strong> cell growth and division</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>inhibition of apoptosis </strong>is a common mechanism in<strong> tumorigenesis</strong>,<strong> mutations </strong>in the<strong> RAS gene </strong>typically<strong> do not </strong>result in the<strong> direct inhibition of apoptotic pathways</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Abnormal tyrosine kinase activity </strong>is often associated with<strong> mutations </strong>in other <strong>proto-oncogenes </strong>and is <strong>not </strong>the primary mechanism of action for<strong> RAS mutations.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option D:&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Up-regulation </strong>of <strong>cytokine receptor </strong>expression is a mechanism that could l<strong>ead to increased cell signaling for proliferation </strong>but is<strong> not </strong>directly related to <strong>RAS mutations.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mutations </strong>in the <strong>RAS gene </strong>lead to <strong>abnormal GTPase activity,</strong> resulting in <strong>uncontrolled cell division and mitogenesis</strong>, which can contribute to <strong>tumorigenesis,</strong> such as in <strong>colon adenocarcinoma.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 286</span></span></strong></span></span></p>",
      "correct_choice_id": 54458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13625,
      "choices": [
        {
          "id": 54461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-Hodgkin&rsquo;s lymphoma</span></span></span></span></p>"
        },
        {
          "id": 54462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Invasive cervical carcinoma</span></span></span></span></p>"
        },
        {
          "id": 54463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kaposi sarcoma </span></span></span></span></p>"
        },
        {
          "id": 54464,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Melanoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old male with a past medical history significant for HIV infection has a CD4 count 120 cells/mm&sup3; . The patient is started on antiretroviral therapy, and further evaluation is planned. All of the following are AIDS defining malignancies except? </span></span></p>",
      "unique_key": "Q7309455",
      "question_audio": null,
      "question_video": null,
      "map_id": 31967,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Melanoma</span></span></strong></span></span><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Melanoma, </strong>while it can occur in patients with <strong>HIV/AIDS</strong>, is<strong> not </strong>considered an <strong>AIDS-defining malignancy</strong>. The conditions listed in <strong>options A, B, and C are specifically </strong>associated with the <strong>immunosuppressed state in AIDS </strong>and have a direct link with<strong> opportunistic infections </strong>and the <strong>patient&#39;s compromised immune system</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Non-Hodgkin&rsquo;s lymphoma</strong>, including <strong>primary lymphoma of the brain</strong>, is an <strong>AIDS-defining malignancy</strong>. This can be<strong> due to the weakened immune system&#39;s </strong>inability to control <strong>oncogenic viruses </strong>like <strong>EBV, </strong>which is associated with<strong> lymphoma.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Invasive cervical carcinoma </strong>is considered an <strong>AIDS-defining </strong>condition due to the association with <strong>human papillomavirus (HPV) </strong>and the<strong> increased risk of this malignancy </strong>in individuals with <strong>compromised immune systems</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Kaposi sarcoma</strong>, caused by<strong> human herpesvirus 8 (HHV-8), </strong>is commonly seen in patients with <strong>AIDS </strong>and is one of the most recognizable<strong> AIDS-defining malignancies</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Non-Hodgkin&rsquo;s lymphoma</strong>, <strong>invasive cervical carcinoma, and Kaposi sarcoma</strong> are considered <strong>AIDS-defining malignancies</strong>, which occur with<strong> increased frequency in patients</strong> with advanced <strong>HIV/AIDS due to their immunocompromised state</strong>. <strong>Melanoma is not part of this category.</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 256</span></span></strong></span></span></p>",
      "correct_choice_id": 54464,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13628,
      "choices": [
        {
          "id": 54473,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To reduce the uptake of glucose</span></span></span></span></p>"
        },
        {
          "id": 54474,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To increase its lifespan and become immortal </span></span></span></span></p>"
        },
        {
          "id": 54475,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To enhance ATP production</span></span></span></span></p>"
        },
        {
          "id": 54476,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To make intermediated required for proliferation</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is studying the metabolic activity of cancer cells and notes that despite adequate oxygen availability, the cells exhibit an increased rate of glycolysis followed by lactic acid fermentation. What is the primary reason for cancer cells to exhibit this metabolic pathway, known as the Warburg effect?</span></span></p>",
      "unique_key": "Q8958577",
      "question_audio": null,
      "question_video": null,
      "map_id": 31969,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) To make intermediated required for proliferation</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Warburg effect </strong>is <strong>aerobic glycolysis. </strong>In cancer cells, even in the presence of <strong>ample oxygen</strong>, there is a <strong>high level of glucose uptake </strong>(so, option &lsquo;a&rsquo; is incorrect)<strong> </strong>and increased conversion of glucose to lactose via the <strong>glycolytic pathway </strong>(only<strong> 2 ATP generated in place of 36 ATP </strong>and so, option &lsquo;c&rsquo; is incorrect). </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warburg effect </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">enables the <strong>synthesis of the macromolecules </strong>and <strong>organelles </strong>that are needed for<strong> rapid cell growth</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correct explanation for the<strong> Warburg effect </strong>is to<strong> provide precursors for the synthesis of macromolecules </strong>and <strong>organelles </strong>necessary for <strong>cell division and rapid tumor growth, </strong>despite the<strong> inefficiency in ATP production</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Warburg effect </strong>is characterized by an<strong> increased uptake of glucose</strong>, <strong>not a reduction</strong>, as <strong>cancer cells have high energy demands</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While the <strong>Warburg effect </strong>contributes to the <strong>cancer cells&#39; survival</strong>, it<strong> does not </strong>directly <strong>increase their lifespan </strong>or cause <strong>immortality</strong>. Instead, it supports the<strong> high metabolic demands of proliferation.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Warburg effect does not </strong>enhance <strong>ATP production </strong>since <strong>aerobic glycolysis is less efficient than oxidative phosphorylation</strong>, generating only<strong> 2 ATP </strong>molecules per<strong> glucose molecule compared to 36 ATP </strong>from <strong>oxidative phosphorylation.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Warburg effect</strong>, or <strong>aerobic glycolysis</strong>, in cancer cells is an adaptation that allows for the <strong>rapid synthesis of the macromolecules </strong>and <strong>organelles </strong>needed for <strong>cell growth and division</strong>, <strong>not for increased ATP production</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 299</span></span></strong></span></span></p>",
      "correct_choice_id": 54476,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13650,
      "choices": [
        {
          "id": 54561,
          "text": "<p><span style=\"font-size:12.0pt;\">Telomerase is not active in somatic cells</span></p>"
        },
        {
          "id": 54562,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a reverse transcriptase</span></p>"
        },
        {
          "id": 54563,
          "text": "<p><span style=\"font-size:12.0pt;\">It's activity is more in Germ cells than non-germ cells</span></p>"
        },
        {
          "id": 54564,
          "text": "<p><span style=\"font-size:12.0pt;\">Double stranded breaks is repaired by telomerase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the false statement?</span></p>",
      "unique_key": "Q1731988",
      "question_audio": null,
      "question_video": null,
      "map_id": 31977,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Double stranded breaks is repaired by telomerase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Telomerase activity </strong>is <strong>absent </strong>in most <strong>normal human somatic cells </strong>because of the<strong> lack of expression of TERT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Telomerase core enzyme </strong>is composed of a<strong> reverse transcriptase </strong>subunit and a<strong> non-coding RNA </strong>used as a <strong>template for elongation</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Germ cells </strong>have higher telomerase activity than non germ cells</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Telomerase </strong>is <strong>not responsible </strong>for<strong> repairing double-stranded DNA breaks</strong>. Its main function is to<strong> elongate telomeres</strong>, which are the <strong>protective ends of chromosomes</strong>, using an <strong>RNA template </strong>that is part of the <strong>enzyme</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Telomerase:&nbsp;</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Telomerase is an enzyme that maintains telomere length.</span></li><li><span style=\"font-size:12.0pt;\">Telomeres: special repetitive DNA sequences (TTAGGG repeats in humans) at chromosome ends.</span></li><li><span style=\"font-size:12.0pt;\">Telomeres protect chromosomes from being recognized as broken DNA.</span></li><li><span style=\"font-size:12.0pt;\">With each cell division, telomeres shorten  contributes to aging and replicative senescence.</span></li></ul>",
      "correct_choice_id": 54564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13652,
      "choices": [
        {
          "id": 54569,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-c</span></span></span></span></p>"
        },
        {
          "id": 54570,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-c, 2-b, 3-a</span></span></span></span></p>"
        },
        {
          "id": 54571,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-c, 3-b</span></span></span></span></p>"
        },
        {
          "id": 54572,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-a, 3-c</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following: </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153127.jpg\" style=\"height:160px; width:700px\" /></p>",
      "unique_key": "Q3190441",
      "question_audio": null,
      "question_video": null,
      "map_id": 31979,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 1-a, 2-c, 3-b</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-131530.JPG\" style=\"height:145px; width:875px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins and Cotran pathologic basis of disease 10th edition page: 323</span></span></strong></span></span></p>",
      "correct_choice_id": 54571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13655,
      "choices": [
        {
          "id": 54581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-b, 3-a, 4-c</span></span></span></span></p>"
        },
        {
          "id": 54582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-a, 4-b</span></span></span></span></p>"
        },
        {
          "id": 54583,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></span></p>"
        },
        {
          "id": 54584,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-b, 2-d, 3-a, 4-c</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the tumor with their biological carcinogens:</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153832.jpg\" style=\"height:179px; width:700px\" /></span></span></p>",
      "unique_key": "Q6408470",
      "question_audio": null,
      "question_video": null,
      "map_id": 31981,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1-b, 2-d, 3-a, 4-c</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/12/screenshot-2024-02-08-153934.jpg\" style=\"height:395px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 54584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13661,
      "choices": [
        {
          "id": 54605,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small cell carcinoma lung</span></span></span></span></p>"
        },
        {
          "id": 54606,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric adenocarcinoma</span></span></span></span></p>"
        },
        {
          "id": 54607,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal cell carcinoma</span></span></span></span></p>"
        },
        {
          "id": 54608,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma thyroid</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common carcinoma associated with inferior vena cava metastasis?</span></span></p>",
      "unique_key": "Q5079709",
      "question_audio": null,
      "question_video": null,
      "map_id": 31985,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Renal cell carcinoma</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma and Hepatocellular carcinoma </strong>is the<strong> most common </strong>malignancy to involve <strong>inferior vena cava</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bronchogenic carcinoma or malignant lymphoma </strong>cause <strong>invasion of the superior vena cava</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma&nbsp;</strong>is known for its<strong> propensity to invade the renal vein </strong>and subsequently the<strong> IVC </strong>due to <strong>its proximity </strong>and <strong>direct vascular connections</strong>. It is the <strong>most </strong>common<strong> malignancy </strong>associated with<strong> IVC </strong>involvement.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Option A: Small cell carcinoma of the lung&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While<strong> lung cancers </strong>can invade <strong>vascular structures, small cell carcinoma of the lung </strong>more commonly involves the<strong> superior vena cava (SVC), </strong>leading to <strong>SVC syndrome, </strong>rather than the IVC.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Gastric adenocarcinoma&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric adenocarcinoma typically <strong>metastasizes to the liver, peritoneum, and lymph nodes</strong>. Direct <strong>invasion into the IVC </strong>is rare with gastric cancers.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Papillary carcinoma of the thyroid :</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroid cancers, including <strong>papillary carcinoma, </strong>primarily spread to <strong>regional neck lymph nodes </strong>and, <strong>less commonly</strong>, to<strong> distant sites</strong>. <strong>Direct IVC invasion </strong>is not characteristic of <strong>thyroid carcinomas</strong>.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Renal cell carcinoma </strong>is the carcinoma most commonly associated with <strong>metastasis to the inferior vena cava</strong>. This type of tumor can <strong>grow within the kidney&#39;s collecting system </strong>and<strong> extend into the renal vein </strong>and then into the<strong> IVC</strong>.</span></span></span></span></p>",
      "correct_choice_id": 54607,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14672,
      "choices": [
        {
          "id": 58649,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thrombophlebitis</span></span></span></p>"
        },
        {
          "id": 58650,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lymphedema</span></span></span></p>"
        },
        {
          "id": 58651,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vasculitis</span></span></span></p>"
        },
        {
          "id": 58652,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tumour embolisation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 49-year-old woman underwent a mastectomy along with axillary lymph node dissection for breast cancer 1 year back. Now she has developed swelling in left arm. Physical examination showed firm skin over left arm and doughy underlying soft tissue. Patient had complained of cellulitis in left arm 3 months back.&nbsp;</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most likely diagnosis?</span></span></span></span></span></p>",
      "unique_key": "Q2540829",
      "question_audio": null,
      "question_video": null,
      "map_id": 31976,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lymphedema</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphedema </strong>is a <strong>common complication </strong>following <strong>mastectomy with axillary lymph node dissection </strong>due to the <strong>obstruction </strong>and <strong>disruption of lymphatic drainage</strong>. The described findings of<strong> firm skin and doughy </strong>underlying soft tissue in the left arm are consistent with<strong> lymphedema</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mastectomy </strong>with <strong>axillary lymph node dissection </strong>leads to <strong>obstruction and disruption of lymphatics in axilla </strong>giving rise to <strong>lymphedema</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Thrombophlebitis </strong>typically presents with <strong>inflammation and thrombosis of superficial veins</strong>, commonly observed in the lower extremities. It is not typically associated with the described findings in the left arm.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Vasculitis </strong>involves <strong>inflammation of blood vessels </strong>and can present with a variety of symptoms depending on the vessels affected. However, it is<strong> not a common surgical complication </strong>following<strong> mastectomy with lymph node dissection </strong>and is less likely in this clinical scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Tumor embolization </strong>refers to the <strong>spread of tumor cells through the bloodstream</strong>, leading to <strong>embolic occlusion of blood vessels</strong>. While tumor emboli can occur, they are typically<strong> small and rare </strong>and would<strong> not manifest </strong>with the described findings.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lymphedema </strong>is a <strong>common complication </strong>following <strong>mastectomy </strong>with <strong>axillary lymph node dissection</strong>.</span></span></span></p>",
      "correct_choice_id": 58650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15498,
      "choices": [
        {
          "id": 61952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Spindle cells </span></span></span></p>"
        },
        {
          "id": 61953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storiform pattern</span></span></span></p>"
        },
        {
          "id": 61954,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Target cells</span></span></span></p>"
        },
        {
          "id": 61955,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antoni A and B pattern</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is seen in schwannnoma?</span></span></span></p>",
      "unique_key": "Q1230627",
      "question_audio": null,
      "question_video": null,
      "map_id": 31959,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Antoni A and B pattern </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>schwannoma</strong>, which is a <strong>tumor arising from Schwann cells </strong>that <strong>myelinate nerve fibers</strong>, the characteristic <strong>histological features </strong>include the <strong>Antoni A </strong>and <strong>Antoni B patterns</strong>:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antoni A pattern</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is defined by <strong>compact</strong>, <strong>highly cellular </strong>areas where <strong>spindle-shaped cells </strong>are <strong>arranged in a palisading fashion</strong>. This creates structures known as Verocay bodies, indicative of a well-organized growth pattern.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antoni B pattern</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is <strong>less cellular </strong>and consists of a <strong>myxoid or microcystic background </strong>with <strong>less organized spindle cells</strong>. This represents a more haphazard growth pattern and can sometimes be associated with cystic changes within the tumor.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Spindle cells</strong> are indeed a <strong>component of schwannomas </strong>but are <strong>not specific to them </strong>as they can be seen in a variety of other neoplastic and reactive processes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Storiform pattern</strong>, characterized by a <strong>cartwheel or mat-like arrangement of cells</strong>, is not typical for schwannoma. It&#39;s more commonly seen in dermatofibroma or malignant fibrous histiocytoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Target cells</strong> are a type of <strong>red blood cell </strong>with a <strong>bullseye appearance </strong>typically associated with conditions like <strong>liver disease </strong>or <strong>hemoglobinopathies</strong>, not schwannomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schwannomas </strong>are characterized by their <strong>distinctive Antoni A </strong>and <strong>B patterns on histology</strong>, which helps <strong>distinguish </strong>them from other <strong>soft tissue tumors</strong>. While <strong>spindle cells </strong>are a feature of <strong>schwannomas</strong>, the <strong>presence of the Antoni A </strong>and <strong>B patterns </strong>is <strong>more pathognomonic</strong>. <strong>Storiform patterns </strong>and <strong>target cells </strong>are associated with <strong>different pathologies </strong>and are not seen in schwannomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1302</span></strong></span></span></p>",
      "correct_choice_id": 61955,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15515,
      "choices": [
        {
          "id": 62020,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Meningioma </span></span></span></p>"
        },
        {
          "id": 62021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hemangioma </span></span></span></p>"
        },
        {
          "id": 62022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glioma </span></span></span></p>"
        },
        {
          "id": 62023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Schwannoma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verocay bodies are seen in:</span></span></p>",
      "unique_key": "Q5789338",
      "question_audio": null,
      "question_video": null,
      "map_id": 31961,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Schwannoma </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Schwannomas </strong>are <strong>well-circumscribed</strong>, <strong>encapsulated masses </strong>that abut the <strong>associated nerve without invading it</strong>. <strong>Microscopically</strong>, they are <strong>comprised of an admixture of dense </strong>and <strong>loose areas </strong>referred to as <strong>Antoni A </strong>and <strong>Antoni B </strong>areas, respectively.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>dense eosinophilic Antoni A areas </strong>often contain <strong>spindle cells </strong>arranged into <strong>cellular intersecting fascicles</strong>. <strong>Palisading of nuclei </strong>is common and <strong>&ldquo;nuclear-free zones</strong>&rdquo; that <strong>lie between the regions </strong>of <strong>nuclear palisading </strong>are termed <strong>Verocay bodies</strong>. In the loose, hypocellular Antoni B areas the spindle cells are spread apart by a prominent myxoid extracellular matrix that may be associated with microcyst formation.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Meningiomas</strong> may exhibit <strong>whorled patterns </strong>and <strong>psammoma bodies</strong>, Verocay bodies are not a feature of meningiomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Hemangiomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>benign tumors </strong>derived from <strong>blood vessels </strong>and can occur in <strong>various tissues </strong>including the <strong>skin and internal organs</strong>. They do not display Verocay bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Gliomas</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are <strong>tumors </strong>arising from <strong>glial cells </strong>in the <strong>central nervous system</strong>, including <strong>astrocytes</strong>, <strong>oligodendrocytes</strong>, and <strong>ependymal cells</strong>. They do not have Verocay bodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Verocay bodies </strong>are seen in <strong>schwannomas </strong>and are characterized by <strong>palisading nuclei </strong>creating <strong>nuclear-free zones </strong>within the <strong>densely cellular Antoni A areas of the tumor</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1302</span></strong></span></span></p>",
      "correct_choice_id": 62023,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16259,
      "choices": [
        {
          "id": 64996,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Foregut carcinoid </span></span></span></span></p>"
        },
        {
          "id": 64997,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior pituitary tumors</span></span></span></span></p>"
        },
        {
          "id": 64998,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancreatic neuroendocrine tumors</span></span></span></span></p>"
        },
        {
          "id": 64999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathyroid hyperplasia</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old patient presents with symptoms of hypercalcemia, peptic ulcer disease, and a pituitary mass on imaging. Given these clinical features, which of the following conditions is least likely to be part of the patient&#39;s underlying syndrome?</span></span></p>",
      "unique_key": "Q5755141",
      "question_audio": null,
      "question_video": null,
      "map_id": 31958,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Posterior pituitary tumors </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN-1</strong>, or <strong>Wermer syndrome</strong> is characterized by <strong>anterior pituitary tumours</strong> and not posterior pituitary tumours. </span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN-1 syndrome</strong> is caused by <strong>germline mutations</strong> in the <strong>MEN1 tumor suppressor gene, </strong>which encodes a protein called menin.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN-1 syndrome involves tumors of the anterior pituitary gland, </strong>not the posterior pituitary. Symptoms are typically caused by excess hormone production, like prolactin or growth hormone.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Foregut carcinoid</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - Foregut carcinoids (including those found in the thymus, lung, and stomach) are <strong>part of the spectrum of MEN-1 syndrome</strong>, although less common compared to other manifestations.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Pancreatic neuroendocrine tumors</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - These tumors are a <strong>hallmark of MEN-1 </strong>and can <strong>produce a variety of symptoms</strong> depending on the <strong>hormone they secrete</strong> (e.g., gastrin, insulin).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Parathyroid hyperplasia</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Primary hyperparathyroidism</strong> due to <strong>parathyroid hyperplasia</strong> is the most common feature of MEN-1 syndrome, causing hypercalcemia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN-1 syndrome,</strong> also known as <strong>Wermer syndrome,</strong> is characterized by <strong>anterior pituitary tumors,</strong> <strong>pancreatic neuroendocrine tumors</strong>, and <strong>parathyroid hyperplasia, </strong>but not by tumors of the posterior pituitary. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1129</span></span></strong></span></span></p>",
      "correct_choice_id": 64997,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16279,
      "choices": [
        {
          "id": 65076,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MEN I </span></span></span></span></p>"
        },
        {
          "id": 65077,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MEN II A</span></span></span></span></p>"
        },
        {
          "id": 65078,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MEN II B </span></span></span></span></p>"
        },
        {
          "id": 65079,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Submucosal neuroma is associated with:</span></span></p>",
      "unique_key": "Q3726333",
      "question_audio": null,
      "question_video": null,
      "map_id": 31960,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) MEN II B </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple Endocrine Neoplasia type II B (MEN II B)&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with <strong>medullary thyroid carcinoma</strong>, <strong>pheochromocytoma</strong>, <strong>mucosal neuromas </strong>(which can be submucosal), <strong>marfanoid habitus</strong>, and <strong>intestinal ganglioneuromas</strong>. <strong>Submucosal neuromas </strong>are a characteristic finding in <strong>MEN II B </strong>and can be seen in the <strong>gastrointestinal tract</strong>, often leading to symptoms like <strong>constipation </strong>or <strong>diarrhea</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Multiple Endocrine Neoplasia type I (MEN I)&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>syndrome </strong>characterized by the <strong>presence of tumors </strong>in the <strong>parathyroid glands</strong>, <strong>pancreatic islet cells</strong>, and the <strong>anterior pituitary gland</strong>. Submucosal neuromas are not typically associated with MEN I.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Multiple Endocrine Neoplasia type II A (MEN II A)&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is a <strong>syndrome </strong>that <strong>includes medullary thyroid carcinoma</strong>, <strong>pheochromocytoma</strong>, and <strong>primary hyperparathyroidism</strong>. It does not typically present with submucosal neuromas.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Submucosal neuromas </strong>are associated with <strong>MEN II B </strong>and can contribute to the diagnosis of this syndrome. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Robbins 10<sup>th</sup> 1130</span></span></strong></span></span></p>",
      "correct_choice_id": 65078,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16285,
      "choices": [
        {
          "id": 65100,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neuroblastoma</span></span></span></span></p>"
        },
        {
          "id": 65101,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephroblastoma</span></span></span></span></p>"
        },
        {
          "id": 65102,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hepatoma</span></span></span></span></p>"
        },
        {
          "id": 65103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ependymoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Homer wright rosettes are seen in:</span></span></p>",
      "unique_key": "Q2515341",
      "question_audio": null,
      "question_video": null,
      "map_id": 31962,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Neuroblastoma </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong>&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Neuroblastoma</strong>, a <strong>tumor arising from the neural crest cells </strong>that <strong>make up the sympathetic nervous system</strong>, commonly <strong>exhibits Homer Wright rosettes</strong>. These <strong>rosettes </strong>are characterized by a <strong>circular arrangement of tumor cells </strong>around a <strong>central area of neurofibrillary material</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as <strong>Wilms&#39; tumor</strong>, <strong>nephroblastoma </strong>is a <strong>kidney tumor </strong>usually <strong>found in children</strong>. It can show other types of rosette formations, but not typically Homer Wright rosettes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hepatoma</strong>, or <strong>hepatocellular carcinoma</strong>, is a <strong>liver tumor </strong>and does not feature the presence of Homer Wright rosettes. Its pathology is markedly different from that of neuroblastic tumors.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ependymomas </strong>are <strong>glial cell tumors </strong>that can <strong>form rosettes </strong>known as <strong>perivascular rosettes </strong>or <strong>ependymal rosettes</strong>, which are distinct from Homer Wright rosettes.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Homer wright rosettes </strong>are seen in <strong>Neuroblastoma.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 480</span></span></strong></span></span></p>",
      "correct_choice_id": 65100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16854,
      "choices": [
        {
          "id": 67376,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical carcinoma</span></span></span></p>"
        },
        {
          "id": 67377,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral carcinoma</span></span></span></p>"
        },
        {
          "id": 67378,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laryngeal papillomatosis.</span></span></span></p>"
        },
        {
          "id": 67379,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anorectal carcinoma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are caused by lethal strains of HPV, except:</span></span></p>",
      "unique_key": "Q1096283",
      "question_audio": null,
      "question_video": null,
      "map_id": 31980,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Laryngeal papillomatosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is commonly caused by <strong>HPV types 6 and 11</strong>, which are considered <strong>low-risk types</strong>. While it can <strong>cause </strong>significant <strong>morbidity </strong>due to <strong>recurrent benign papillomas </strong>in the <strong>larynx</strong>, it is not typically associated with the development of cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Cervical carcinoma:</strong> <strong>Persistent infection </strong>with these <strong>high-risk HPV types </strong>especially <strong>HPV 16, 18, 31 and 33 </strong>, can lead to the <strong>progression of cervical dysplasia </strong>to invasive carcinoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Oral carcinoma:</strong> <strong>HPV infection</strong>, especially with <strong>types 16 and 18</strong>, has been <strong>linked to the development of oral </strong>and <strong>oropharyngeal cancers</strong>, particularly in the tonsillar and base of the tongue areas.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Anorectal carcinoma:</strong> <strong>High-risk HPV types</strong>, including <strong>16 and 18</strong>, are implicated in the <strong>development of anal </strong>and <strong>anorectal carcinomas</strong>. These cancers are more prevalent in individuals with persistent HPV infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Laryngeal papillomatosis </strong>is typically caused by the <strong>low-risk human papillomavirus </strong>(HPV) <strong>types 6 and 11</strong>, which are <strong>not commonly associated with malignancy</strong>. In contrast, high-risk HPV types, particularly 16 and 18, are associated with an increased risk of developing cancers such as cervical carcinoma, oral carcinoma, and anorectal carcinoma.</span></span></span></p>",
      "correct_choice_id": 67378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16287,
      "choices": [
        {
          "id": 65108,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 65109,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma</span></p>"
        },
        {
          "id": 65110,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hyperthyroidism</span></p>"
        },
        {
          "id": 65111,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a feature of Sipple Syndrome?</span></p>",
      "unique_key": "Q4125691",
      "question_audio": null,
      "question_video": null,
      "map_id": 31963,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hyperthyroidism</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hyperthyroidism </strong>is <strong>not a feature of MEN 2A</strong>.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Sipple syndrome = MEN type 2A (Multiple Endocrine Neoplasia type 2A)</span></p></li><li><span style=\"font-size:12.0pt;\">It is characterized by the classic triad:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Medullary thyroid carcinoma (MTC)</span></li><li><span style=\"font-size:12.0pt;\">Pheochromocytoma</span></li><li><span style=\"font-size:12.0pt;\">Parathyroid hyperplasia or adenoma  leading to hyperparathyroidism&nbsp;</span></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u>:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Pheochromocytoma </strong>is a characteristic <strong>feature of MEN 2A </strong>and presents as a <strong>catecholamine-secreting tumor </strong>typically originating in the adrenal medulla.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:&nbsp;Medullary thyroid carcinoma </strong>(MTC) is a <strong>neuroendocrine tumor </strong>of the <strong>thyroid </strong>and a <strong>principal feature of MEN 2A</strong>. It arises from the parafollicular C-cells of the thyroid gland and secretes calcitonin.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;Primary hyperparathyroidism </strong>is <strong>part of the MEN 2A syndrome </strong>and is <strong>due to hyperplasia </strong>or <strong>adenoma of the parathyroid glands </strong>leading to <strong>excessive secretion of parathyroid hormone </strong>(PTH).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">While <strong>pheochromocytoma</strong>, <strong>medullary thyroid carcinoma</strong>, and <strong>hyperparathyroidism </strong>are part of the <strong>Sipple syndrome</strong>, hyperthyroidism is not.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1130</strong></span></p>",
      "correct_choice_id": 65110,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16866,
      "choices": [
        {
          "id": 67424,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metaphase is distinct </span></span></span></p>"
        },
        {
          "id": 67425,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to contamination with infectious agents</span></span></span></p>"
        },
        {
          "id": 67426,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">High mitotic rate</span></span></span></p>"
        },
        {
          "id": 67427,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficient tissue sample</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The cytogenicity of solid tumors is not easily assessed especially in carcinoma cervix because:</span></span></p>",
      "unique_key": "Q5905795",
      "question_audio": null,
      "question_video": null,
      "map_id": 31986,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Due to contamination with infectious agents </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Contamination </strong>with <strong>infectious agents </strong>could <strong>introduce foreign genetic material</strong>, making it <strong>challenging to obtain accurate </strong>and <strong>reliable cytogenetic results</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">While a <strong>high mitotic rate</strong> is a <strong>characteristic of rapidly dividing cancer cells</strong>, it <strong>doesn&#39;t </strong>necessarily <strong>hinder cytogenetic analysis</strong>. In fact, a <strong>high mitotic rate </strong>is often <strong>beneficial for cytogenetic studies </strong>as it provides more cells in the dividing phase for analysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficient tissue sample</strong>: A <strong>deficient tissue sample </strong>may indeed <strong>hinder cytogenetic analysis</strong>. If the <strong>sample is insufficient </strong>or of <strong>low quality</strong>, it may not yield enough viable cells for proper analysis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficient tissue sampling </strong>like <strong>sampling from non-representative areas </strong>or the <strong>necrotic areas </strong>will <strong>impair the results </strong>in most of the <strong>solid tumors </strong>but the <strong>commonest problem with cancer of the cervix </strong>is the <strong>high contamination rate</strong>. So, option &lsquo;B&rsquo; is better than option &lsquo;D&rsquo;.</span></span></span></p>",
      "correct_choice_id": 67425,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16874,
      "choices": [
        {
          "id": 67456,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caused by HPV</span></span></span></p>"
        },
        {
          "id": 67457,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexually transmitted</span></span></span></p>"
        },
        {
          "id": 67458,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Progresses to malignancy</span></span></span></p>"
        },
        {
          "id": 67459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs in genitalia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about condylomata acuminata except which of the following:</span></span></p>",
      "unique_key": "Q4159471",
      "question_audio": null,
      "question_video": null,
      "map_id": 31988,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Progresses to malignancy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>HPV infection </strong>is associated with certain <strong>cancers</strong>, particularly <strong>cervical cancer</strong>, <strong>condylomata acuminata </strong>themselves are <strong>benign </strong>and <strong>rarely progress to malignancy</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Caused by HPV</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>true</strong>. Condylomata acuminata, also known as genital warts, are caused by certain types of the human papillomavirus (HPV), particularly HPV types 6 and 11.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sexually transmitted</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true </strong>as well. HPV, which causes condylomata acuminata, is transmitted through sexual contact.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Occurs in genitalia</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>true</strong>. Condylomata acuminata typically appear in the moist mucocutaneous regions of the genitalia and are characterized by their cauliflower-like appearance.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Condylomata acuminata </strong>are <strong>benign lesions </strong>caused by <strong>HPV </strong>and are <strong>sexually transmitted</strong>. They typically <strong>appear in the genitalia </strong>and, while they may persist or recur, they <strong>rarely progress to malignancy</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup>/ 970</span></strong></span></span></p>",
      "correct_choice_id": 67458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}